| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 15.420 | 27.914 | 33.312 | 37.609 | 38.436 | 40.481 |
| Total Income - EUR | - | - | - | - | 15.420 | 27.914 | 33.312 | 37.609 | 38.436 | 40.481 |
| Total Expenses - EUR | - | - | - | - | 177 | 102 | 99 | 96 | 96 | 110 |
| Gross Profit/Loss - EUR | - | - | - | - | 15.244 | 27.812 | 33.213 | 37.514 | 38.340 | 40.371 |
| Net Profit/Loss - EUR | - | - | - | - | 14.781 | 27.043 | 32.284 | 36.498 | 32.635 | 34.363 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vultur Promedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 15.103 | 58.034 | 32.515 | 36.724 | 43.020 | 35.776 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 21.823 | 25.775 | 28.527 | 1.783 | 16.485 |
| Cash | - | - | - | - | 15.103 | 36.211 | 6.740 | 8.197 | 41.236 | 19.291 |
| Shareholders Funds | - | - | - | - | 14.823 | 27.094 | 32.335 | 36.550 | 32.687 | 34.415 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 280 | 30.940 | 179 | 174 | 10.333 | 1.360 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Vultur Promedica S.r.l.